Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Ethnopharmacological Survey of Medicinal Plants Used by Local Herbalists and Traditional Healers for the Treatment of Cancer in Jordan

Author(s): Yahia Tabaza* and Talal Aburjai

Volume 10, Issue 3, 2024

Published on: 23 May, 2023

Article ID: e150523216940 Pages: 14

DOI: 10.2174/2215083810666230515161319

Price: $65

conference banner
Abstract

Background: As many Jordanians include herbs in their treatment, an ethnopharmacological survey was conducted to identify the most prescribed plants for the treatment of cancer by local herbalists and traditional healers in Jordan, aiming to encourage the prescription that is based on scientific evidence, to tackle some important practices in traditional healing, and to provide candidates for the isolation of new anticancer agents.

Methods: Thirty-two Jordanian herbalists and traditional healers were interviewed. Both the use value and frequency of citation were implemented as quantitative methods to demonstrate the relative importance of a chosen species for the treatment of cancer. Furthermore, literature was screened for evidences that supported or opposed the use of the plants of interest.

Results: It was revealed that 31 plants are currently used in Jordan for the treatment of cancer, with Curcuma longa and Ephedra foeminea being the most used ones.

Conclusion: It was noticed that the use of many prescribed plants could be rationalised by in vitro and/or in vivo studies. However, more attention should be paid by practitioners to some important aspects, such as the method of use and preparation of plants, their interaction with chemotherapeutic agents and the differences in their efficacy against different cancer types.

Graphical Abstract

[1]
Ajibesin KK, Ekpo BA, Bala DN, Essien EE, Adesanya SA. Ethnobotanical survey of Akwa Ibom State of Nigeria. J Ethnopharmacol 2008; 115(3): 387-408.
[http://dx.doi.org/10.1016/j.jep.2007.10.021] [PMID: 18053664]
[2]
Jaradat NA, Ayesh OI, Anderson C. Ethnopharmacological survey about medicinal plants utilized by herbalists and traditional practitioner healers for treatments of diarrhea in the West Bank/Palestine. J Ethnopharmacol 2016; 182: 57-66.
[http://dx.doi.org/10.1016/j.jep.2016.02.013] [PMID: 26883246]
[3]
Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 2016; 79(3): 629-61.
[http://dx.doi.org/10.1021/acs.jnatprod.5b01055] [PMID: 26852623]
[4]
Vedavathy S. Scope and importance of traditional medicine. Indian J Tradit Knowl 2003; 2(20): 236.
[5]
Cox PA. The ethnobotanical approach to drug discovery: strengths and limitations. Ciba Found Symp 1994; 185: 25-36.
[6]
Afifi FU, Wazaify M, Jabr M, Treish E. The use of herbal preparations as complementary and alternative medicine (CAM) in a sample of patients with cancer in Jordan. Complement Ther Clin Pract 2010; 16(4): 208-12.
[http://dx.doi.org/10.1016/j.ctcp.2010.05.001] [PMID: 20920804]
[7]
Khalaf I, Callister LC. Cultural meanings of childbirth: Muslim women living in Jordan. J Holist Nurs 1997; 15(4): 373-88.
[http://dx.doi.org/10.1177/089801019701500405] [PMID: 9397746]
[8]
Abu-Darwish MS, Efferth T. Medicinal plants from near east for cancer therapy. Front Pharmacol 2018; 9: 56.
[http://dx.doi.org/10.3389/fphar.2018.00056] [PMID: 29445343]
[9]
Zaid H, Silbermann M, Ben-Arye E, Saad B. Greco-arab and islamic herbal-derived anticancer modalities: from tradition to molecular mechanisms. Evid Based Complement Alternat Med 2012; 2012: 349040.
[10]
Abdelhalim A, Aburjai T, Hanrahan J, Abdel-Halim H. Medicinal plants used by traditional healers in Jordan, the Tafila region. Pharmacogn Mag 2017; 13(49): 95.
[http://dx.doi.org/10.4103/0973-1296.203975] [PMID: 28479733]
[11]
Khalil RB. Attitudes, beliefs and perceptions regarding truth disclosure of cancer-related information in the Middle East: A review. Palliat Support Care 2013; 11(1): 69-78.
[http://dx.doi.org/10.1017/S1478951512000107] [PMID: 23171758]
[12]
Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144(8): 1941-53.
[http://dx.doi.org/10.1002/ijc.31937] [PMID: 30350310]
[13]
Abdel-Razeq H, Attiga F, Mansour A. Cancer care in Jordan. Hematol Oncol Stem Cell Ther 2015; 8(2): 64-70.
[http://dx.doi.org/10.1016/j.hemonc.2015.02.001] [PMID: 25732671]
[14]
WHO.Prevalence of tobacco smoking. 2015. Available from: https://www.who.int/gho/tobacco/use/en/
[15]
Al-Sayaideh A, Nimri O, Arqoub K, Al-Zaghal M, Halasa W. Cancer Incidence in Jordan - 2012 Non communicable diseases Directorate, Cancer Prevention Department, Jordan Cancer Registry. 2012. Available from: http:/www.moh.gov.jo/Echobusv3.0/SystemAssets/a05a084b-3781-4979-a217-2184d5d57ede.pdf
[16]
Jordan fact sheets In: Globocan. World Health Organization 2020.
[17]
Twiss KC. Transformations in an early agricultural society: Feasting in the southern Levantine Pre-Pottery Neolithic. J Anthropol Archaeol 2008; 27(4): 418-42.
[http://dx.doi.org/10.1016/j.jaa.2008.06.002]
[18]
Patai R. Kingdom of Jordan. Princeton University Press 2015.
[19]
Tristram HB. The Land of Moab: travels and discoveries on the east side of the Dead Sea and the Jordan. Harper and brothers 1873.
[20]
Levy TE, Adams RB, Najjar M, et al. Reassessing the chronology of Biblical Edom: new excavations and 14C dates from Khirbat en-Nahas (Jordan). Antiquity 2004; 78(302): 865-79.
[http://dx.doi.org/10.1017/S0003598X0011350X]
[21]
LaBianca ØS, Younker RW, Levy TE. The kingdoms of Ammon, Moab and Edom: The archaeology of society in Late Bronze/Iron Age Transjordan (ca. 1400-500 BCE). Archaeol Soc Holy 1995; 399-415.
[22]
Albright WF. The Jordan valley in the bronze age. Annu Am Sch Orient Res 1924; 6: 13-74.
[http://dx.doi.org/10.2307/3768510]
[23]
Mazar B. The aramean empire and its relations with Israel. Biblical Archaeologist 1962; 25(4): 98-120.
[http://dx.doi.org/10.2307/3210938]
[24]
Ortloff CR. The water supply and distribution system of the Nabataean city of Petra (Jordan), 300 BC-AD 300. Camb Archaeol J 2005; 15(1): 93-109.
[http://dx.doi.org/10.1017/S0959774305000053]
[25]
Al-Akra M, Jahangir Ali M, Marashdeh O. Development of accounting regulation in Jordan. Int J Account 2009; 44(2): 163-86.
[http://dx.doi.org/10.1016/j.intacc.2009.03.003]
[26]
Kennedy D. The Roman frontier in Arabia (Jordanian sector)-S. Thomas parker, romans and saracens. A history of the Arabian frontier (American Schools of Oriental Research, Dissertation Series 6, Eisenbrauns, Winona Lake, Indiana 1986). Pp. xiii+ 247, 12 plates, 74 l. J Rom Archaeol 1992; 5: 473-89.
[27]
Walmsley AG. Fi- l (Pella) and the cities of North Jordan during the Umayyad and Abbasid periods. Stud Hist Archaeol Jordan 1992; pp. 377-84.
[28]
Walmsley A, Damgaard K. The Umayyad congregational mosque of Jarash in Jordan and its relationship to early mosques. Antiquity 2005; 79(304): 362-78.
[http://dx.doi.org/10.1017/S0003598X00114152]
[29]
Corbett E. Competitive archaeology in Jordan: narrating identity from the Ottomans to the Hashemites. University of Texas Press 2015.
[30]
Wimmer SJ. A new stela of ramesses II in Jordan in the context of egyptian royal stelae in the levant. Third international congress on the archaeology of the ancient near East Paris April 18. 2002; pp. 1-19.
[31]
Chatford Clark DL. Viewing the liturgy: A space syntax study of changing visibility and accessibility in the development of the Byzantine church in Jordan. World Archaeol 2007; 39(1): 84-104.
[http://dx.doi.org/10.1080/00438240601148798]
[32]
Goor A. The history of the date through the ages in the Holy Land. Econ Bot 1967; 21(4): 320-40.
[http://dx.doi.org/10.1007/BF02863157]
[33]
Hudaib M, Mohammad M, Bustanji Y, et al. Ethnopharmacological survey of medicinal plants in Jordan, Mujib Nature Reserve and surrounding area. J Ethnopharmacol 2008; 120(1): 63-71.
[http://dx.doi.org/10.1016/j.jep.2008.07.031] [PMID: 18760342]
[34]
Al-Eisawi DM. Flora of Jordan Checklist, Revised. The University of Jordan Press 2013; p. 187.
[35]
Bolson M, Hefler SM, Dall’Oglio CEI, Gasparotto JA, Cardozo JEL, Junior ELC. Ethno-medicinal study of plants used for treatment of human ailments, with residents of the surrounding region of forest fragments of Paraná, Brazil. J Ethnopharmacol 2015; 161: 1-10.
[http://dx.doi.org/10.1016/j.jep.2014.11.045] [PMID: 25482361]
[36]
Alzweiri M, Sarhan AA, Mansi K, Hudaib M, Aburjai T. Ethnopharmacological survey of medicinal herbs in Jordan, the Northern Badia region. J Ethnopharmacol 2011; 137(1): 27-35.
[http://dx.doi.org/10.1016/j.jep.2011.02.007] [PMID: 21335083]
[37]
Gürdal B, Kültür Ş. An ethnobotanical study of medicinal plants in Marmaris (Muğla, Turkey). J Ethnopharmacol 2013; 146(1): 113-26.
[http://dx.doi.org/10.1016/j.jep.2012.12.012] [PMID: 23261486]
[38]
Weckerle CS, de Boer HJ, Puri RK, van Andel T, Bussmann RW, Leonti M. Recommended standards for conducting and reporting ethnopharmacological field studies. J Ethnopharmacol 2018; 210: 125-32.
[http://dx.doi.org/10.1016/j.jep.2017.08.018] [PMID: 28834697]
[39]
Tas F, Ustuner Z, Can G, et al. The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncol 2005; 44(2): 161-7.
[http://dx.doi.org/10.1080/02841860510007549] [PMID: 15788296]
[40]
Taïbi K, Abderrahim LA, Ferhat K, et al. Ethnopharmacological study of natural products used for traditional cancer therapy in Algeria. Saudi Pharm J 2020; 28(11): 1451-65.
[http://dx.doi.org/10.1016/j.jsps.2020.09.011] [PMID: 33250653]
[41]
Aboul-Enein AM, El-Ela FA, Shalaby EA, El-Shemy HA. Traditional medicinal plants research in Egypt: Studies of antioxidant and anticancer activities. J Med Plants Res 2012; 6(5): 689-703.
[42]
Vaidya ADB, Amonkar AJ, Bhatt NS, Parikh PM. Complementary and alternative medicine for cancer care in India: basic and clinical perspective Alternative and Complementary Therapies for Cancer. Springer 2010; pp. 31-82.
[http://dx.doi.org/10.1007/978-1-4419-0020-3_3]
[43]
Qi F, Li A, Inagaki Y, et al. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends 2010; 4(6): 297-307.
[PMID: 21248427]
[44]
Ali-Shtayeh MS, Jamous RM, Jamous RM. Herbal preparation use by patients suffering from cancer in Palestine. Complement Ther Clin Pract 2011; 17(4): 235-40.
[http://dx.doi.org/10.1016/j.ctcp.2011.06.002] [PMID: 21982140]
[45]
Ramsewak RS, DeWitt DL, Nair MG. Cytotoxicity, antioxidant and anti-inflammatory activities of Curcumins I-III from Curcuma longa. Phytomedicine 2000; 7(4): 303-8.
[http://dx.doi.org/10.1016/S0944-7113(00)80048-3] [PMID: 10969724]
[46]
Debnath S, Saloum D, Dolai S, et al. Dendrimer-curcumin conjugate: A water soluble and effective cytotoxic agent against breast cancer cell lines. Anticancer Agents Med Chem 2013; 13(10): 1531-9.
[http://dx.doi.org/10.2174/18715206113139990139] [PMID: 23387971]
[47]
Labidi S, Ennouri S, Rachdi H, et al. Use of complementary and alternative medicine in cancer: A Tunisian single-center experience. Bull Cancer 2020; 107(2): 209-14.
[http://dx.doi.org/10.1016/j.bulcan.2019.10.007] [PMID: 32000968]
[48]
Ben-Arye E, Mahajna J, Aly R, et al. Exploring an herbal “wonder cure” for cancer: A multidisciplinary approach. J Cancer Res Clin Oncol 2016; 142(7): 1499-508.
[http://dx.doi.org/10.1007/s00432-016-2175-7] [PMID: 27155666]
[49]
Salehi M, Naghavi MR, Bahmankar M. A review of Ferula species: Biochemical characteristics, pharmaceutical and industrial applications, and suggestions for biotechnologists. Ind Crops Prod 2019; 139: 111511.
[http://dx.doi.org/10.1016/j.indcrop.2019.111511]
[50]
Asadi-Samani M, Kooti W, Aslani E, Shirzad H. A systematic review of Iran’s medicinal plants with anticancer effects. J Evid Based Complementary Altern Med 2016; 21(2): 143-53.
[http://dx.doi.org/10.1177/2156587215600873] [PMID: 26297173]
[51]
Alshammari S. Cytotoxic activity of Ferula assa-foetida and Astragalus sarcocolla against cervical epithelial and colon carcinoma cell lines 2016.
[52]
Iranshahy M, Farhadi F, Paknejad B, et al. Gummosin, a sesquiterpene coumarin from Ferula assa-foetida is preferentially cytotoxic to human breast and prostate cancer cell lines. Avicenna J Phytomed 2019; 9(5): 446-53.
[PMID: 31516858]
[53]
Wang CZ, Anderson S, Du W, He TC, Yuan CS. Red ginseng and cancer treatment. Chin J Nat Med 2016; 14(1): 7-16.
[http://dx.doi.org/10.1186/s13020-019-0231-3] [PMID: 26850342]
[54]
Lai J-N, Wu C-T, Wang J-D. Prescription pattern of Chinese herbal products for breast cancer in Taiwan: a population-based study. Evidence-Based Complement Altern Med 2012.
[55]
Efferth T, Miyachi H, Bartsch H. Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy. Cancer Genomics Proteomics 2007; 4(2): 81-91.
[PMID: 17804870]
[56]
Yun TK. Panax ginseng-a non-organ-specific cancer preventive? Lancet Oncol 2001; 2(1): 49-55.
[http://dx.doi.org/10.1016/S1470-2045(00)00196-0] [PMID: 11905620]
[57]
Dhanamani M, Devi SL, Kannan S. Ethnomedicinal plants for cancer therapy-a review. Hygeia JD Med 2011; 3(1): 1-10.
[58]
Abdel-Wahhab MA, Gamil K, El-Kady AA, El-Nekeety AA, Naguib KM. Therapeutic effects of korean red ginseng extract in egyptian patients with chronic liver diseases. J Ginseng Res 2011; 35(1): 69-79.
[http://dx.doi.org/10.5142/jgr.2011.35.1.069]
[59]
Kabbaj F, Meddah B, Cherrah Y, Faouzi E. Ethnopharmacological profile of traditional plants used in Morocco by cancer patients as herbal therapeutics. Phytopharmacology 2012; 2(2): 243-56.
[60]
Matsunaga H, Katano M, Yamamoto H, Fujito H, Mori M, Takata K. Cytotoxic activity of polyacetylene compounds in Panax ginseng C.A. Meyer. Chem Pharm Bull (Tokyo) 1990; 38(12): 3480-2.
[http://dx.doi.org/10.1248/cpb.38.3480] [PMID: 2092947]
[61]
Li KK, Yao CM, Yang XW. Four new dammarane-type triterpene saponins from the stems and leaves of Panax ginseng and their cytotoxicity on HL-60 cells. Planta Med 2012; 78(2): 189-92.
[http://dx.doi.org/10.1055/s-0031-1280320] [PMID: 22034065]
[62]
Huang J, Tang X, Ikejima T, et al. A new triterpenoid from Panax ginseng exhibits cytotoxicity through p53 and the caspase signaling pathway in the HepG2 cell line. Arch Pharm Res 2008; 31(3): 323-9.
[http://dx.doi.org/10.1007/s12272-001-1159-8] [PMID: 18409045]
[63]
Park IH, Piao LZ, Kwon SW, et al. Cytotoxic dammarane glycosides from processed ginseng. Chem Pharm Bull (Tokyo) 2002; 50(4): 538-40.
[http://dx.doi.org/10.1248/cpb.50.538] [PMID: 11964005]
[64]
Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005. BMC Womens Health 2007; 7(1): 4.
[http://dx.doi.org/10.1186/1472-6874-7-4] [PMID: 17397542]
[65]
Smith M, Boon HS. Counseling cancer patients about herbal medicine. Patient Educ Couns 1999; 38(2): 109-20.
[http://dx.doi.org/10.1016/S0738-3991(99)00058-0] [PMID: 14528703]
[66]
Chan YS, Cheng LN, Wu JH, et al. A review of the pharmacological effects of Arctium lappa (burdock). Inflammopharmacology 2011; 19(5): 245-54.
[http://dx.doi.org/10.1007/s10787-010-0062-4] [PMID: 20981575]
[67]
Predes FS, Ruiz ALTG, Carvalho JE, Foglio MA, Dolder H. Antioxidative and in vitro antiproliferative activity of Arctium lappa root extracts. BMC Complement Altern Med 2011; 11(1): 25.
[http://dx.doi.org/10.1186/1472-6882-11-25] [PMID: 21429215]
[68]
Elansary HO, Mahmoud EA. Egyptian herbal tea infusions’ antioxidants and their antiproliferative and cytotoxic activities against cancer cells. Nat Prod Res 2015; 29(5): 474-9.
[http://dx.doi.org/10.1080/14786419.2014.951354] [PMID: 25141946]
[69]
Tai J, Cheung S, Wu M, Hasman D. Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro. Phytomedicine 2012; 19(5): 436-43.
[http://dx.doi.org/10.1016/j.phymed.2011.12.012] [PMID: 22325591]
[70]
Bakhotmah BA, Alzahrani HA. Self-reported use of complementary and alternative medicine (CAM) products in topical treatment of diabetic foot disorders by diabetic patients in Jeddah, Western Saudi Arabia. BMC Res Notes 2010; 3(1): 254.
[http://dx.doi.org/10.1186/1756-0500-3-254] [PMID: 20925956]
[71]
Nickavar B, Mojab F, Javidnia K, Amoli MAR. Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch C J Biosci 2003; 58(9-10): 629-31.
[http://dx.doi.org/10.1515/znc-2003-9-1004] [PMID: 14577620]
[72]
Abdollahi FM, Shojaii A. Efficacy of Iranian traditional medicine in the treatment of epilepsy. Biomed Res Int 2013; 2013: 692751.
[http://dx.doi.org/10.1155/2013/692751]
[73]
Gilani AH, Aziz N, Khurram IM, Chaudhary KS, Iqbal A. Bronchodilator, spasmolytic and calcium antagonist activities of Nigella sativa seeds (Kalonji): A traditional herbal product with multiple medicinal uses. J Pak Med Assoc 2001; 51(3): 115-20.
[PMID: 11381824]
[74]
Özgüven M, Şekeroğlu N. Agricultural practices for high yield and quality of black cumin (Nigella sativa L.) cultivated in Turkey. International Symposium on Medicinal and Nutraceutical Plants 756. 329-8.
[75]
Tahraoui A, El-Hilaly J, Israili ZH, Lyoussi B. Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province). J Ethnopharmacol 2007; 110(1): 105-17.
[http://dx.doi.org/10.1016/j.jep.2006.09.011] [PMID: 17052873]
[76]
Lestari MW, Soemardji AA, Fidrianny I. Review of traditional use, pharmacological effects and toxicity of medicinal plants for women’s health in Indonesia. Asian J Pharm Clin Res 2016; 9(1): 32-7.
[77]
Shafi G, Munshi A, Hasan TN, Alshatwi AA, Jyothy A, Lei DKY. Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella sativa. Cancer Cell Int 2009; 9(1): 29.
[http://dx.doi.org/10.1186/1475-2867-9-29] [PMID: 19943925]
[78]
M Musharraf H, Saiful Islam Arman M. Prophetic medicine is the cheapest, safest and the best remedy in the prevention and treatment of hypertension (high blood pressure) - a mini review. J Mol Biol 2018; 3(6): 245-50.
[http://dx.doi.org/10.15406/ijmboa.2018.03.00084]
[79]
Khan A, Chen H-C, Tania M, Zhang D-Z. Anticancer activities of Nigella sativa (black cumin). Afr J Tradit Complement Altern Med 2011; 8(S5): 226-32.
[http://dx.doi.org/10.4314/ajtcam.v8i5S.10] [PMID: 22754079]
[80]
Khan FA, Mahmood T, Ali M, Saeed A, Maalik A. Pharmacological importance of an ethnobotanical plant: Capsicum annuum L. Nat Prod Res 2014; 28(16): 1267-74.
[http://dx.doi.org/10.1080/14786419.2014.895723] [PMID: 24650229]
[81]
Koffi-Nevry R, Kouassi KC, Nanga ZY, Koussémon M, Loukou GY. Antibacterial activity of two bell pepper extracts: Capsicum annuum L. and Capsicum frutescens. Int J Food Prop 2012; 15(5): 961-71.
[http://dx.doi.org/10.1080/10942912.2010.509896]
[82]
Hernández-Ortega M, Ortiz-Moreno A, Hernández-Navarro MD, Chamorro-Cevallos G, Dorantes-Alvarez L, Necoechea-Mondragón H. Antioxidant, antinociceptive, and anti-inflammatory effects of carotenoids extracted from dried pepper (Capsicum annuum L.). J Biomed Biotechnol 2012; 2012: 524019.
[83]
Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51(2): 159-212.
[PMID: 10353985]
[84]
Clark R, Lee S-H. Anticancer properties of capsaicin against human cancer. Anticancer Res 2016; 36(3): 837-43.
[PMID: 26976969]
[85]
Al-Samydai A, Al-Mamoori F, Abdelnabi H, Aburjai T. An updated review on anticancer activity of capsaicin. Int J Sci Technol Res 2019; 8: 2625-31.
[86]
Maoka T, Mochida K, Kozuka M, et al. Cancer chemopreventive activity of carotenoids in the fruits of red paprika Capsicum annuum L. Cancer Lett 2001; 172(2): 103-9.
[http://dx.doi.org/10.1016/S0304-3835(01)00635-8] [PMID: 11566483]
[87]
Iorizzi M, Lanzotti V, De Marino S, et al. New glycosides from Capsicum annuum L. var. acuminatum. Isolation, structure determination, and biological activity. J Agric Food Chem 2001; 49(4): 2022-9.
[http://dx.doi.org/10.1021/jf0013454] [PMID: 11308362]
[88]
Bagheri S, Ebadi N, Taghipour Z, Manayi A, Toliyat T. Preparation of Saussurea costus traditional oil and investigation of different parameters for standardization. Res J Pharmacogn 2018; 5(2): 51-6.
[89]
Abdallah EM, Qureshi KA, Ali AMH, Elhassan GO. Evaluation of some biological properties of Saussurea costus crude root extract. Biosci Biotechnol Res Commun 2017; 10(4): 601-11.
[http://dx.doi.org/10.21786/bbrc/10.4/2]
[90]
Pandey MM, Rastogi S, Rawat AKS. Saussurea costus: Botanical, chemical and pharmacological review of an ayurvedic medicinal plant. J Ethnopharmacol 2007; 110(3): 379-90.
[http://dx.doi.org/10.1016/j.jep.2006.12.033] [PMID: 17306480]
[91]
Li Y, Xu C, Zhang Q, Liu JY, Tan RX. In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases. J Ethnopharmacol 2005; 98(3): 329-33.
[http://dx.doi.org/10.1016/j.jep.2005.01.020] [PMID: 15814268]
[92]
Parekh J, Karathia N. Screening of some traditionally used medicinal plants for potential antibacterial activity. Indian J Pharm Sci 2006; 68(6)
[93]
Wang X, Fang G, Pang Y. Chinese medicines in the treatment of prostate cancer: From formulas to extracts and compounds. Nutrients 2018; 10(3): 283.
[http://dx.doi.org/10.3390/nu10030283] [PMID: 29495626]
[94]
Wu TS, Leu YL, Kuoh CS, Jiang SD, Chen CF, Lee KH. Cytotoxic principles from Saussurea lappa and Corydalis turtshaninovii f. yanhusuo. J Chin Chem Soc 1997; 44(3): 357-9.
[http://dx.doi.org/10.1002/jccs.199700053]
[95]
Algier LA, Hanoglu Z, Özden G, Kara F. The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey. Eur J Oncol Nurs 2005; 9(2): 138-46.
[http://dx.doi.org/10.1016/j.ejon.2005.03.010] [PMID: 15899593]
[96]
Ceylan S, Hamzaoğlu O, Kömürcü S, Beyan C, Yalçin A. Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complement Ther Med 2002; 10(2): 94-9.
[http://dx.doi.org/10.1054/ctim.2002.0527] [PMID: 12481957]
[97]
Sertel S, Eichhorn T, Plinkert PK, Efferth T. Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma. Anticancer Res 2011; 31(1): 81-7.
[PMID: 21273584]
[98]
Abaza MSI, Orabi KY, Al-Quattan E, Al-Attiyah RJ. Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer. Cancer Cell Int 2015; 15(1): 46.
[http://dx.doi.org/10.1186/s12935-015-0194-0] [PMID: 26074733]
[99]
Berdowska I, Zieliński B, Fecka I, Kulbacka J, Saczko J, Gamian A. Cytotoxic impact of phenolics from Lamiaceae species on human breast cancer cells. Food Chem 2013; 141(2): 1313-21.
[http://dx.doi.org/10.1016/j.foodchem.2013.03.090] [PMID: 23790919]
[100]
Vimala S, Norhanom AW, Yadav M. Anti-tumour promoter activity in Malaysian ginger rhizobia used in traditional medicine. Br J Cancer 1999; 80(1-2): 110-6.
[http://dx.doi.org/10.1038/sj.bjc.6690329] [PMID: 10389986]
[101]
Wang CZ, Qi LW, Yuan CS. Cancer chemoprevention effects of ginger and its active constituents: potential for new drug discovery. Am J Chin Med 2015; 43(7): 1351-63.
[http://dx.doi.org/10.1142/S0192415X15500767] [PMID: 26477795]
[102]
Kim HJ, Chang WK, Kim MK, Lee SS, Choi BY. Dietary factors and gastric cancer in Korea: A case-control study. Int J Cancer 2002; 97(4): 531-5.
[http://dx.doi.org/10.1002/ijc.10111] [PMID: 11802218]
[103]
Shukla Y, Singh M. Cancer preventive properties of ginger: A brief review. Food Chem Toxicol 2007; 45(5): 683-90.
[http://dx.doi.org/10.1016/j.fct.2006.11.002] [PMID: 17175086]
[104]
Liu Y, Whelan RJ, Pattnaik BR, et al. Terpenoids from Zingiber officinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53. PLoS One 2012; 7(12): e53178.
[http://dx.doi.org/10.1371/journal.pone.0053178] [PMID: 23300887]
[105]
de Lima RMT, dos Reis AC, de Menezes AAPM, et al. Protective and therapeutic potential of ginger (Zingiber officinale) extract and [6]-gingerol in cancer: A comprehensive review. Phytother Res 2018; 32(10): 1885-907.
[http://dx.doi.org/10.1002/ptr.6134] [PMID: 30009484]
[106]
Kundu JK, Na H-K, Surh Y-J. Ginger-derived phenolic substances with cancer preventive and therapeutic potential. Food Factors for Health Promotion. Karger Publishers 2009; pp. 182-92.
[http://dx.doi.org/10.1159/000212750]
[107]
Elkady AI, Abuzinadah OA, Baeshen NA, Rahmy TR. Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale. J Biomed Biotechnol 2012; 2012: 614356.
[108]
Suresh K, Sivakumar K, Vijayaanand MA, Rajalingam K, Rajkamal G. Antilipidperoxidative and antioxidant effects of Zingiber officinale roscoe root extract in 7, 12-dimethylbenz [a] anthracene induced oral carcinogenesis. Pharmacol online 2010; 2: 689-701.
[109]
Mahmoud T, Gairola S. Traditional knowledge and use of medicinal plants in the Eastern Desert of Egypt: a case study from Wadi El-Gemal National Park. Faslnamah-i Giyahan-i Daruyi 2013; 1(6): 10-7.
[110]
Miller LH, Su X. Artemisinin: Discovery from the Chinese herbal garden. Cell 2011; 146(6): 855-8.
[http://dx.doi.org/10.1016/j.cell.2011.08.024] [PMID: 21907397]
[111]
Efferth T. From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Seminars in cancer biology. Elsevier 2017; pp. 65-83.
[http://dx.doi.org/10.1016/j.semcancer.2017.02.009]
[112]
El-Sharabasy HM. Acaricidal activities of Artemisia judaica L. extracts against Tetranychus urticae Koch and its predator Phytoseiulus persimilis Athias Henriot (Tetranychidae: Phytoseiidae). J Biopesticides 2010; 3(2): 514.
[113]
Fahd AN, Omar MN, Ramzi AM, Ali SA, Abdullah AA-M. Cytotoxic, antimicrobial and antioxidant activities and phytochemical analysis of Artemisia judaica and A. sieberi in Saudi Arabia. Afr J Pharm Pharmacol 2020; 14(8): 278-84.
[http://dx.doi.org/10.5897/AJPP2020.5175]
[114]
Basu Majumder A, Bera B, Rajan A. Tea statistics: Global scenario. Int J Tea Sci 2010; 8(1): 121-4.
[115]
Komes D, Horžić D, Belščak A, Ganić KK, Vulić I. Green tea preparation and its influence on the content of bioactive compounds. Food Res Int 2010; 43(1): 167-76.
[http://dx.doi.org/10.1016/j.foodres.2009.09.022]
[116]
Khan N, Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 2008; 269(2): 269-80.
[http://dx.doi.org/10.1016/j.canlet.2008.04.014] [PMID: 18501505]
[117]
Fujiki H, Suganuma M, Imai K, Nakachi K. Green tea: cancer preventive beverage and/or drug. Cancer Lett 2002; 188(1-2): 9-13.
[http://dx.doi.org/10.1016/S0304-3835(02)00379-8] [PMID: 12406542]
[118]
Suganuma M, Okabe S, Sueoka N, et al. Green tea and cancer chemoprevention. Mutat Res 1999; 428(1-2): 339-44.
[http://dx.doi.org/10.1016/S1383-5742(99)00059-9] [PMID: 10518005]
[119]
Nicastro HL, Ross SA, Milner JA. Garlic and onions: Their cancer prevention properties. Cancer Prev Res 2015; 8(3): 181-9.
[http://dx.doi.org/10.1158/1940-6207.CAPR-14-0172] [PMID: 25586902]
[120]
Fleischauer AT, Poole C, Arab L. Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers. Am J Clin Nutr 2000; 72(4): 1047-52.
[http://dx.doi.org/10.1093/ajcn/72.4.1047] [PMID: 11010950]
[121]
Galeone C, Pelucchi C, Levi F, et al. Onion and garlic use and human cancer1-3. Am J Clin Nutr 2006; 84(5): 1027-32.
[http://dx.doi.org/10.1093/ajcn/84.5.1027] [PMID: 17093154]
[122]
Darzynkiewicz Z, Traganos F, Wu JM, Chen S. Chinese herbal mixture PC SPES in treatment of prostate cancer (review) Int J Oncol 2000; 17(4): 729-36.
[http://dx.doi.org/10.3892/ijo.17.4.729] [PMID: 10995884]
[123]
Hsiao W, Liu L. The role of traditional Chinese herbal medicines in cancer therapy-from TCM theory to mechanistic insights. Planta Med 2010; 76(11): 1118-31.
[http://dx.doi.org/10.1055/s-0030-1250186] [PMID: 20635308]
[124]
Lam W, Bussom S, Guan F, Jiang Z, Zhang W, Gullen EA. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med 2010; 2(45): 45ra59-9.
[http://dx.doi.org/10.1126/scitranslmed.3001270]
[125]
Liu SH, Cheng YC. Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol 2012; 140(3): 614-23.
[http://dx.doi.org/10.1016/j.jep.2012.01.047] [PMID: 22326673]
[126]
Saif MW, Li J, Lamb L, et al. First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer. Cancer Chemother Pharmacol 2014; 73(2): 373-80.
[http://dx.doi.org/10.1007/s00280-013-2359-7] [PMID: 24297682]
[127]
Yen Y, So S, Rose M, et al. Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma. Anticancer Res 2009; 29(10): 4083-92.
[PMID: 19846955]
[128]
Sovak M, Seligson AL, Konas M, et al. Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst 2002; 94(17): 1275-80.
[http://dx.doi.org/10.1093/jnci/94.17.1275] [PMID: 12208892]
[129]
Morsi MK, El-Magoli B, Saleh NT, El-Hadidy EM, Barakat HA. Study of antioxidants and anticancer activity licorice Glycyrrhiza glabra extracts. Egypt J Nutr Feeds 2008; 2(33): 177-203.
[130]
Sheela ML, Ramakrishna MK, Salimath BP. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol 2006; 6(3): 494-8.
[http://dx.doi.org/10.1016/j.intimp.2005.07.002] [PMID: 16428085]
[131]
Hibasami H, Iwase H, Yoshioka K, Takahashi H. Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells. Int J Mol Med 2005; 16(2): 233-6.
[http://dx.doi.org/10.3892/ijmm.16.2.233] [PMID: 16012754]
[132]
Hibasami H, Iwase H, Yoshioka K, Takahashi H. Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells. Int J Mol Med 2006; 17(2): 215-9.
[http://dx.doi.org/10.3892/ijmm.17.2.215] [PMID: 16391818]
[133]
Thirugnanam S, Xu L, Ramaswamy K, Gnanasekar M. Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP. Oncol Rep 2008; 20(6): 1387-92.
[PMID: 19020719]
[134]
Budavari S, O’neil MJ, Smith A, Heckelman PE, Obenchain JR Jr, Gallipeau JAR. The Merck index: An encyclopedia of chemicals drugs, and biologicals. In: Whitehouse Station.NJ: Merck & Co Inc. 1996; 450: p. 1674.
[135]
Savini I, Arnone R, Catani MV, Avigliano L. Origanum vulgare induces apoptosis in human colon cancer Caco2 cells. Nutr Cancer 2009; 61(3): 381-9.
[http://dx.doi.org/10.1080/01635580802582769] [PMID: 19373612]
[136]
Balusamy SR, Perumalsamy H, Huq MA, Balasubramanian B. Anti-proliferative activity of Origanum vulgare inhibited lipogenesis and induced mitochondrial mediated apoptosis in human stomach cancer cell lines. Biomed Pharmacother 2018; 108: 1835-44.
[http://dx.doi.org/10.1016/j.biopha.2018.10.028] [PMID: 30372889]
[137]
Koldaş S, Demirtas I, Ozen T, Demirci MA, Behçet L. Phytochemical screening, anticancer and antioxidant activities of Origanum vulgare L. ssp. viride (Boiss.) Hayek, a plant of traditional usage. J Sci Food Agric 2015; 95(4): 786-98.
[http://dx.doi.org/10.1002/jsfa.6903] [PMID: 25200133]
[138]
Liu N, Yang HL, Wang P, et al. Functional proteomic analysis revels that the ethanol extract of Annona muricata L. induces liver cancer cell apoptosis through endoplasmic reticulum stress pathway. J Ethnopharmacol 2016; 189: 210-7.
[http://dx.doi.org/10.1016/j.jep.2016.05.045] [PMID: 27224241]
[139]
Fidianingsih I, Handayani ES. Annona muricata aqueous extract suppresses T47D breast cancer cell proliferation. Universa Med 2014; 33(1): 19-26.
[140]
Pieme CA, Kumar SG, Dongmo MS, et al. Antiproliferative activity and induction of apoptosis by Annona muricata (Annonaceae) extract on human cancer cells. BMC Complement Altern Med 2014; 14(1): 516.
[http://dx.doi.org/10.1186/1472-6882-14-516] [PMID: 25539720]
[141]
Kadan S, Rayan M, Rayan A. Anticancer activity of anise (Pimpinella anisum L.) seed extract. Open Nutraceuticals J 2013; 6(1): 1-5.
[http://dx.doi.org/10.2174/1876396001306010001]
[142]
Gülçın İ, Oktay M, Kıreçcı E, Küfrevıoǧlu Öİ. Screening of antioxidant and antimicrobial activities of anise (Pimpinella anisum L.) seed extracts. Food Chem 2003; 83(3): 371-82.
[http://dx.doi.org/10.1016/S0308-8146(03)00098-0]
[143]
Chicca A, Adinolfi B, Martinotti E, et al. Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines. J Ethnopharmacol 2007; 110(1): 148-53.
[http://dx.doi.org/10.1016/j.jep.2006.09.013] [PMID: 17052874]
[144]
Tsai YL, Chiu CC, Yi-Fu Chen J, Chan KC, Lin SD. Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis. J Ethnopharmacol 2012; 143(3): 914-9.
[http://dx.doi.org/10.1016/j.jep.2012.08.032] [PMID: 22971663]
[145]
Al-Snafi AE. Medical importance of Anthemis nobilis (Chamaemelum nobile)-a review. Asian J Pharm Sci Technol 2016; 6(2): 89-95.
[146]
Mostafapour Kandelous H, Salimi M, Khori V, Rastkari N, Amanzadeh A, Salimi M. Mitochondrial apoptosis induced by Chamaemelum nobile extract in breast cancer cells. Iran J Pharm Res 2016; 15: 197-204.
[PMID: 28228817]
[147]
Bratty MA, Govindaram LK, Govindaram LK, et al. High performance thin-layer chromatography and in vitro cytotoxic studies on ethanol extract of Matricaria chamomilla L. (Asteraceae) flowers. Trop J Pharm Res 2021; 18(9): 1969-76.
[http://dx.doi.org/10.4314/tjpr.v18i9.27]
[148]
Kamali AM, Nikseresht M, Delaviz H, Barmak MJ, Servatkhah M, Ardakani MT. In vitro cytotoxic activity of Matricaria Chamomilla root extract in human breast cancer cell line MCF-7. Life Sci J 2014; 11(5s): 403-6.
[149]
Mohsenzadeh F, Chehregani A, Amiri H. Chemical composition, antibacterial activity and cytotoxicity of essential oils of Tanacetum parthenium in different developmental stages. Pharm Biol 2011; 49(9): 920-6.
[http://dx.doi.org/10.3109/13880209.2011.556650] [PMID: 21592001]
[150]
Yousefzadi M, Ebrahimi SN, Sonboli A, Miraghasi F, Ghiasi S, Arman M. Cytotoxicity, antimicrobial activity and composition of essential oil from Tanacetum balsamita L. subsp. balsamita. Nat Prod Commun 2009; 4(1): 1934578X0900400126.
[151]
Hafidh RR, Abdulamir AS, Abu Bakar F, et al. Novel anticancer activity and anticancer mechanisms of Brassica oleracea L. var. Capitata f. rubra. Eur J Integr Med 2013; 5(5): 450-64.
[http://dx.doi.org/10.1016/j.eujim.2013.06.004]
[152]
Thangam R, Suresh V, Rajkumar M, et al. Antioxidant and in vitro anticancer effect of 2-pyrrolidinone rich fraction of Brassica oleracea var. Capitata through induction of apoptosis in human cancer cells. Phytother Res 2013; 27(11): 1664-70.
[http://dx.doi.org/10.1002/ptr.4908] [PMID: 23292857]
[153]
Kamal AM, Chowdhury KA, Shill LK, Hossain MR, Islam N, Anaytulla IA, et al. Phytochemical screening, cytotoxic and thrombolytic activity of extract of Brassica oleracea flower (cauliflower). Glob J Pharmacol 2015; 9(1): 115-20.
[154]
Kim KK, Singh AP, Singh RK, et al. Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells. Int J Oncol 2012; 40(1): 227-35.
[PMID: 21922132]
[155]
Singh AP, Singh RK, Kim KK, et al. Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum-resistant ovarian cancer cells to paraplatin. Phytother Res 2009; 23(8): 1066-74.
[http://dx.doi.org/10.1002/ptr.2667] [PMID: 19172579]
[156]
da Silva RR, Rodrigues ABL, Farias ALF, Simões RC, Pinheiro MT. Chemical composition and in vitro antioxidant, cytotoxic, antimicrobial, and larvicidal activities of the essential oil of Mentha piperita L. (Lamiaceae). Sci World J 2017; 2017: 4927214.
[157]
Sun Z, Wang H, Wang J, Zhou L, Yang P. Chemical composition and anti-inflammatory, cytotoxic and antioxidant activities of essential oil from leaves of Mentha piperita grown in China. PLoS One 2014; 9(12): e114767.
[http://dx.doi.org/10.1371/journal.pone.0114767] [PMID: 25493616]
[158]
Hajlaoui H, Mighri H, Aouni M, Gharsallah N, Kadri A. Chemical composition and in vitro evaluation of antioxidant, antimicrobial, cytotoxicity and anti-acetylcholinesterase properties of Tunisian Origanum majorana L. essential oil. Microb Pathog 2016; 95: 86-94.
[http://dx.doi.org/10.1016/j.micpath.2016.03.003] [PMID: 26997648]
[159]
Al Dhaheri Y, Eid A, AbuQamar S, et al. Mitotic arrest and apoptosis in breast cancer cells induced by Origanum majorana extract: Upregulation of TNF-α and downregulation of survivin and mutant p53. PLoS One 2013; 8(2): e56649.
[http://dx.doi.org/10.1371/journal.pone.0056649] [PMID: 23451065]
[160]
Khlifi D, Sghaier RM, Amouri S, Laouini D, Hamdi M, Bouajila J. Composition and anti-oxidant, anti-cancer and anti-inflammatory activities of Artemisia herba-alba, Ruta chalpensis L. and Peganum harmala L. Food Chem Toxicol 2013; 55: 202-8.
[http://dx.doi.org/10.1016/j.fct.2013.01.004] [PMID: 23333573]
[161]
Lamchouri F, Settaf A, Cherrah Y, et al. In vitro cell-toxicity of Peganum harmala alkaloids on cancerous cell-lines. Fitoterapia 2000; 71(1): 50-4.
[http://dx.doi.org/10.1016/S0367-326X(99)00117-3] [PMID: 11449470]
[162]
Majdalawieh AF, Carr RI. In vitro investigation of the potential immunomodulatory and anti-cancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum). J Med Food 2010; 13(2): 371-81.
[http://dx.doi.org/10.1089/jmf.2009.1131] [PMID: 20210607]
[163]
Tammina SK, Mandal BK, Ranjan S, Dasgupta N. Cytotoxicity study of Piper nigrum seed mediated synthesized SnO2 nanoparticles towards colorectal (HCT116) and lung cancer (A549) cell lines. J Photochem Photobiol B 2017; 166: 158-68.
[http://dx.doi.org/10.1016/j.jphotobiol.2016.11.017] [PMID: 27915029]
[164]
Jöhrer K, Stuppner H, Greil R, Çiçek SS. Structure-guided identification of black cohosh (Actaea racemosa) triterpenoids with in vitro activity against multiple myeloma. Molecules 2020; 25(4): 766.
[http://dx.doi.org/10.3390/molecules25040766] [PMID: 32053921]
[165]
Durgo K, Belščak-Cvitanović A, Stančić A, Franekić J, Komes D. The bioactive potential of red raspberry (Rubus idaeus L.) leaves in exhibiting cytotoxic and cytoprotective activity on human laryngeal carcinoma and colon adenocarcinoma. J Med Food 2012; 15(3): 258-68.
[http://dx.doi.org/10.1089/jmf.2011.0087] [PMID: 22082102]
[166]
Szymanowska U, Baraniak B, Bogucka-Kocka A. Antioxidant, anti-inflammatory, and postulated cytotoxic activity of phenolic and anthocyanin-rich fractions from polana raspberry (Rubus idaeus L.) fruit and juice-in vitro study. Molecules 2018; 23(7): 1812.
[http://dx.doi.org/10.3390/molecules23071812] [PMID: 30037097]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy